Alan R. Stewart
CIK 1705492 · Chief Financial Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.00M
Companies
3
Total Filings
45
Lifetime Open-Market Net
-$1.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-01 | SSTI | Grant (A) | +8,111 | $0 | EDGAR |
| 2024-01-04 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | +7,282 | $13.1K | EDGAR |
| 2023-03-15 | SSTI | Sell (S) | −310 | -$10.9K | EDGAR |
| 2023-03-10 | SSTI | Disp (D) | −419 | -$14.9K | EDGAR |
| 2023-03-01 | SSTI | Mixed | +708 | -$487.2K | EDGAR |
| 2023-01-04 | SSTI | Exer (M) | +4,868 | $14.9K | EDGAR |
| 2022-12-14 | SSTI | Sell (S) | −245 | -$8.3K | EDGAR |
| 2022-12-09 | SSTI | Sell (S) | −319 | -$10.4K | EDGAR |
| 2022-11-21 | SSTI | Sell (S) | −542 | -$18.2K | EDGAR |
| 2022-11-15 | SSTI | Sell (S) | −14,972 | -$524.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.